Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Denali Therapeutics Inc. (DNLI)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and DNLI | ||
|---|---|---|
| S&P 500 | DNLI | |
| Start Date | Jan-01-2018 | Jan-31-2018 |
| Start Price | $2,476.46 | $23.26 |
| End Date | May-01-2024 | May-17-2024 |
| End Price | $5,018.39 | $20.51 |
| Number Monthly Prices | 77 | 77 |
| Min Date | Dec-01-2018 | Jul-31-2018 |
| Min Price | $3,185.80 | $12.59 |
| Max Date | Apr-01-2024 | Dec-31-2020 |
| Max Price | $5,243.77 | $83.76 |
| Total Return | 43.02% | -11.82% |
| Annualized Return | 5.73% | -1.94% |
| Current Value of $1,000 Purchase | $1,430 | $882 |
| Number Returns | 2,926 | 2,926 |
| Average Return | 15.92% | 34.80% |
| Minimum Return | -25.54% | -81.57% |
| Maximum Return | 64.60% | 565.29% |
| Number Profitable Returns | 2,343 | 1,645 |
| Percent Profitable Returns | 80.08% | 56.22% |
| Number Unprofitable Returns | 583 | 1,281 |
| Percent Unprofitable Returns | 19.92% | 43.78% |
| Profitable to Unprofitable Returns Ratio | 4.02 | 1.28 |
DNLI Performance Table and Chart
DNLI Dollar-cost Average
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates